MelanomaÂ’s Road In the ERA of Immuno-Oncology

Dr. Omid Hamid MD of the Chief, Translational Research & Immuno-Oncology 
Director, Cutaneous Malignancies, The Angeles Clinic and Research Institute discusses how Immuno-Oncology will affect not only melanoma but many other disease states within oncology.